Articles

What about oligometastatic therapy in prostate cancer?

BJMO - , issue ,

Prof. P. Ost , PhD and Prof. B. Tombal

In a pro and con debate, Prof. Piet Ost and Prof. Betrand Tombal discussed the potential of metastasisdirected therapy for patients with oligorecurrent prostate cancer.

Read more

What about oligometastatic therapy in prostate cancer?

BJMO - volume 12, issue 10, march 2018

Prof. P. Ost , PhD and Prof. B. Tombal

In a pro and con debate, Prof. Piet Ost and Prof. Betrand Tombal discussed the potential of metastasisdirected therapy for patients with oligorecurrent prostate cancer.

Read more